© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
477040 |
As an accredited 3-Bromo-5-(Trifluoromethyl)Toluene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-5-(Trifluoromethyl)Toluene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
3-Bromo-5-(Trifluoromethyl)Toluene, with model identifier 147503-54-2, stands out among organic intermediates not just for its striking trifluoromethyl group, but for the tangible impact it brings to laboratories and manufacturing lines. Often, the complexity of a chemical’s name masks its true value, but here each part of the molecular structure—bromo, trifluoromethyl, toluene—has a story rooted in real-world chemistry. Relationship-driven connections between functional groups set this compound apart, helping it reach sectors including pharmaceuticals and materials science.
Someone who’s worked long hours at the bench knows the difference a well-selected chemical makes. 3-Bromo-5-(Trifluoromethyl)Toluene is no generic halogenated aromatic; its unique pairing of bromine at the meta position and a highly electronegative trifluoromethyl group at the para sets the stage for selective reactivity. I’ve personally seen this kind of scaffold—where electron donation from toluene’s methyl group sits in tension with electron withdrawal by trifluoromethyl—guiding smarter reactions where you want change at the bromine site, while keeping everything else untouched. Many traditional precursors can’t juggle such balance, leading to extra purification steps or lost material.
3-Bromo-5-(Trifluoromethyl)Toluene merges the basic toluene skeleton with two strategic substituents. That methyl group doesn’t just stake out territory; it tunes the reactivity and helps keep the molecule soluble in organic solvents. Introduce a trifluoromethyl group—known for both chemical resilience and ability to lower pKa or boiling points—and the molecular personality changes. Add bromine at the other meta position, and you gain an entry point for cross-coupling or nucleophilic displacement without scrambling your product.
Many who work in medicinal chemistry or agrochemical design know how precious selectivity can be. Choosing a precursor with the right pairing of reactivity and stability isn’t just academic; it translates into fewer side products, higher yields, and tighter regulatory compliance.
Scaling up from milligram experiments to kilogram synthesis taught me some hard truths about chemical intermediates. Some compounds only reveal their drawbacks once you start looking for consistency under pressure. 3-Bromo-5-(Trifluoromethyl)Toluene, though, delivers reliable results across scales, from bench-top Suzuki couplings to pilot plant arylations. Chemists can introduce complex aromatic frameworks or insert this motif directly into active pharmaceutical ingredients (APIs).
Because bromine acts as a good leaving group, the compound feeds into a wide spectrum of classic cross-coupling protocols like Suzuki-Miyaura and Buchwald-Hartwig. Drug discovery teams working on fluorous drugs or proposing novel ligand architectures often pick trifluoromethylated aromatics for stronger metabolic stability, higher lipophilicity, and improved oral bioavailability.
Specification matters most when consistency is the difference between a successful scale-up and a costly failure. The purity of 3-Bromo-5-(Trifluoromethyl)Toluene is often rated to commercial-grade norms, generally reaching above 97 percent. This ensures that impurities from mother liquors or by-products do not interfere with downstream reactions.
Boiling at a moderate range, soluble in most organic solvents, and presenting as a clear to light yellow liquid, the compound integrates easily into glovebox and open-air procedures alike. An aromatic core provides both stability and ease of handling, minimizing the risk of decomposition during storage or transfer. These are not just technical details; they form the backbone of any robust laboratory routine.
Anyone who’s sorted through catalogs for aryl bromides or trifluoromethylated arenes knows the value of a nuanced molecular framework. Some competitors line up in the form of 4-bromo or 2-bromo trifluoromethyl toluenes, but the 3-bromo-5-trifluoromethyl orientation introduces unique electronic effects.
Direct comparisons with 4-bromo variants reveal quite different patterns in coupling efficiency and selectivity. Meta-bromination creates less electronic density at the bromine’s position, which changes the ease of substitution for nucleophilic or palladium-catalyzed reactions. In cases where electron-rich arenes can fail to couple cleanly or promote unwanted side reactions, this compound’s balanced electron profile pushes selectivity and yield forward.
From a safety standpoint, the tri-halogenated structure makes a difference as well. Experience shows that certain bromo-fluoro aromatics resist oxidation and thermolysis better, preventing degradation during shipment or extended storage. Not every intermediate can survive the long supply chains that modern pharma manufacturing demands.
At the chemical design stage, 3-Bromo-5-(Trifluoromethyl)Toluene gives molecule architects the freedom to add new complexity with fewer synthetic steps. In early-stage API development, this building block supplies a ready entry for further functionalization through well-established palladium-catalysis. My own experience with fluorine-rich intermediates mirrors published case studies: simplifying multi-step routes by reducing the need to protect or deprotect side-chain groups.
Added fluorous content correlates with greater metabolic stability for small molecule drugs. In agrochemical design, the same structural features deter breakdown in harsh outdoor conditions. Each functional group on this molecule does measurable work—bromine as a handle for C–C or C–N bond formation, trifluoromethyl for electronic tuning, and methyl for maintaining aromatic character without overcomplicating the structure.
Being easy to source in high purity, 3-Bromo-5-(Trifluoromethyl)Toluene’s market impact shows up in the chemical portfolios of pharmaceutical, specialty polymer, and agrochemical firms. In pharmaceuticals, it frames drug molecules structurally similar to candesartan or anti-cancer candidates, where a single fluorine swap can make the difference between failure and blockbuster hit.
Materials chemists craft new photoresistant coatings, liquid crystal aligners, and performance polymers from trifluro-substituted frameworks. Their demands focus on structural reliability and precise electronic tuning. In my consulting projects, requests for purer and more controllable interactions with transition metals almost always circle back to intermediates combining halogen and trifluoromethyl features.
Environmental stewardship matters now more than ever. 3-Bromo-5-(Trifluoromethyl)Toluene stands as an example of how modern intermediates support green chemistry goals. Higher purity and controlled site-specific reactivity translate into better atom economy and less waste per kilogram of product. Avoiding long protecting-group strategies reduces solvent use and shrinks the carbon footprint of the synthesis workflow.
Downstream, major projects using this intermediate benefit from fewer hazardous byproducts. Brominated aromatics often raise red flags for toxicity, but well-chosen trifluoromethyl substituents offer stability without persistent environmental risk. Experienced chemists understand that process simplicity supports both workplace safety and regulatory approval.
Some intermediates come from far corners of the globe, often with unclear documentation or inconsistent specifications. Partners in the life sciences sector have learned to demand analytical traceability and robust support for every batch. Each consignment of 3-Bromo-5-(Trifluoromethyl)Toluene integrates with standardized testing—be it gas chromatography, mass spectrometry, or NMR—giving end-users assurance about functional group integrity and absence of unanticipated contaminants.
Reluctance to compromise on traceability and repeatability isn’t just theoretical. In pharmaceutical manufacturing, a minor change in impurity profiles can force months-long revalidation and cost millions. Choosing a reliable intermediate avoids regulatory hurdles and accelerates scale-up timelines.
From a practical purchasing standpoint, shifts in global demand for fluorinated and halogenated arenes have pushed 3-Bromo-5-(Trifluoromethyl)Toluene into the spotlight. Growth in targeted cancer drug pipelines and the hunger for more selective crop protection drives market demand forward.
Researchers keep pressing for intermediates that provide more structural options without trade-offs in safety or purity. In the last five years, patents listing this motif as a synthetic intermediate increased, reflecting its growing acceptance in medicinal chemistry workflows. A strong supply chain, paired with regulatory-awareness, gives innovative firms the freedom to respond to changing project needs without costly re-tooling.
Seasoned chemists often voice their approval for compounds like 3-Bromo-5-(Trifluoromethyl)Toluene in roundtable discussions. These are not just abstract advantages—faster reaction times, greater site selectivity, or the comfort of well-characterized byproducts. They translate into less rework and more freedom in experimental design. I’ve talked to colleagues in API production who cite the value of a versatile aryl bromide that tolerates both hydrophilic and hydrophobic transformations, especially when managing sensitive or expensive catalysts.
This intermediate outpaces mono-halogenated analogs by consistently supporting higher yield per step and less formation of inseparable side products. Modern drug scaffolds favor fluorous aromatics, recognizing trifluoromethyl’s unique effect on metabolic pathways and solubility. Companies unwilling to compromise on quality see this group as a ticket to scalable, patentable, and potent small molecules.
Recent advances in process intensification reward those who choose intermediates that dovetail with both flow and batch platforms. 3-Bromo-5-(Trifluoromethyl)Toluene, with its predictable melting, boiling, and reactivity profiles, adapts to both. This matters to manufacturers hoping to bypass old bottlenecks or adopt continuous synthesis models.
Needing to switch from small-scale discovery to pilot-plant runs, process teams rely on intermediates that won’t introduce surprises or require costly re-engineering of reaction conditions. The stability of this intermediate under mild as well as high-throughput conditions makes it a front-runner for companies chasing speed to market. In my own work, I’ve seen this versatility save weeks of optimization, freeing up time and resources for more innovative work.
As competition intensifies in sectors like pharmaceuticals and agriculture, the subtle uniqueness of intermediates often drives patent opportunities. The 3-bromo, 5-trifluoromethyl substitution pattern is distinctive enough to support new claims on synthetic routes, opening pathways to original APIs or differentiated crop chemicals. Strong patent coverage on the backbone allows firms to secure marketplace protection and define product lifecycles with greater confidence.
In a climate dominated by increasingly sophisticated competitors, the choice of starting material can make or break future intellectual property positions. A versatile scaffold like this enables chemists to build novel analogues not yet seen in prior art, expanding freedom to operate and spurring chemical creativity on the bench.
Earned trust in product quality and reliability comes from consistent use and thorough documentation. First-hand experience matters as much as published literature in choosing safer, more reliable reagents. 3-Bromo-5-(Trifluoromethyl)Toluene merits attention because its documented properties align with the hands-on realities of modern labs—purity, stability, reliable supply, and clear labeling supported by data you can actually check.
Experienced organizations put trust in suppliers who don’t just advertise purity but back it up with Certificates of Analysis, batch history, and analytical support. This practice—so common in the highest-performing pharma and specialty chemical companies—ensures users aren’t left guessing about what’s really in the bottle. For research-intensive applications, every edge in consistency counts.
The future of chemical manufacturing does not belong to generic, one-size-fits-all intermediates. The growing need for site-selectivity, process efficiency, and regulatory clarity raises the bar for all players. New therapies, more durable materials, and advanced crop solutions depend on picking the right molecular frameworks early on. In a market hungry for both innovation and predictability, 3-Bromo-5-(Trifluoromethyl)Toluene demonstrates how carefully balanced structure leads to real-world impact.
As chemical manufacturing evolves, this substance’s combination of functional utility and environmental responsibility continues to steer best practices. Knowledge grows not from abstraction, but from the lessons learned at the lab bench and manufacturing floor. The steady demand for this intermediate testifies to its role as both a reliable partner in synthesis and a springboard toward the next generation of products transforming our world.
